Call for Abstracts

 

Notification

Submitting authors are notified by email if their proposal was accepted or declined in July 2019.

Authors chosen to present need to register for the advocacy summit by September 1, 2019.


Disclosure Statement

SOPHE policy requires potential presenters to disclose any proprietary, financial, professional or other personal interests in the material to be presented. This includes past employment, serving as a consultant, conducting clinical trials, serving on an advisory committee, inclusion in a speaker’s bureau, owning stock, holding patents, etc.

As a condition of submission, SOPHE requires that the presenting author check acknowledge and agree to the following statement:

I declare that to the best of my knowledge all my co‐authors and I have no proprietary, financial, professional or other personal interest in any product, service and/or company that could be construed as influencing the material proposed for presentation in our abstract.

I have read and agree to the disclosure statement.

As a condition of submission, SOPHE also requires that the presenting author acknowledge and agree to the following statement:

I declare that my co-authors and I agree to the following if our abstract submission is accepted for presentation at SOPHE 2019: (1) To present the work as described in the submitted abstract and to present the session format assigned by the planning committee; (2) Each author/co-author attending the conference must register for the conference and assume responsibility for their own registration, lodging and transportation costs. (Please note that if any accepted abstract author withdraws with late notice or fails to show, this will impact future opportunities to present at SOPHE meetings); (3) If selected for a presentation, a copy of our slides will be provided to SOPHE one week prior to the start of the conference, so that they can be made available to attendees and available at our assigned session; and (4) Acknowledge and accept that our presentation may be video or audio taped and made available for future continuing education purposes.

I have read and agree to the disclosure statement.